FDA Investigator Emilie E Kahn

Emilie E Kahn has conducted inspections on 46 sites in 4 countries as of 09 Dec 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
46
Last Inspection Date:
09 Dec 2019
Investigator Role:
FDA Investigation Participant
Redica ID:
100001177
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Korea (Republic of), Germany
FDA Investigators that have inspected at least one site in common with Emilie E Kahn:
Alan L Truong, Alan M Barker, Alan M Roberts, Alanna L Mussawwir Bias, Amy L Mccarthy, Amy S Graf, Andrew J Barrowcliff, Andrew J Lang, Anthony F Lorenzo, Anthony J Ladner, Art O Czabaniuk, Aurora Miha Trifanov, Ava M Bowman, Azza Talaat, Bei Y He, Benjamin J Dastoli, Bleta Vuniqi, Brent T Hall, Brett R Havranek, Brian P Putz, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Caroline H Le, Caryn M Mcnab, Cathie S Marshall, Charles L Zhou, Charles Yuanchia Kuo, PhD, Cheng H Yen, Christian D Lynch (CDL), Christina A Miller, Christina Capacci Daniel, PhD, Christopher D Leach, Cody J Alley, Constantin Y Philopoulos, Courtney E Hillier, Cristina Ausin Moreno, PhD, Crystal L Parks, Daniel J Brown, Daniel J Gorski, Daniel J Grabicki, Daniel L Obrzut, Daniel W Stoll, David A Paterson, David J Gasparovich, David L Miser, David L Wilson, Deanna L Lampley, Deborah M Trout, Debra I Love, Denarvis C Mendenhall, Dennis Cantellops Paite, Diane L Raccasi, Dr. Zhihao Qiu (Peter), PhD, Dylan C Grippi, Eboni S Funderburk, Edwin Jao, Emest F Bizjak, Emily J Orban, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Eric T Huebler, Erika V Butler, Esther C Broner, PhD, Francis A Guidry, Franklin D Heisler, Gary C Pecic, Jr, Geneve M Parks, Gregory R Dill, Hans T Meyers, Hokenson, Hyung Yul Lee, Ifueko Osemwota, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Lane, James K Ireland, James L Dunnie, Jr, James R Evans, Janet L Bowen, Janete A Eaker, Janete A Oliveira, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Downie, Jennifer M Gogley, Jeremy W Rotton, Joan A Loreng, John M Seale, Jon P Antoniou, Joohi Castelvetere, Jose M Cayuela, Joseph A Piechocki, Joseph R Lambert, Joseph T Madak, Joslyn K Brunelle, PhD, Kallol Biswas, Karen Emasley Joseph, Karen M Kondas, Katharine M Oaks, Kathryn A Guardiola, Kathryn G Brown, Kejun Cheng, Kevin P Regan, Kumar G Janoria, Larry K Austin, Laureen F Kononen, Lauren E Sexton, Lauren M Lilly, PhD, LCDR Chad N Thompson, LCDR Sean Byrd, Lequita M Mayhew, Leslie A Paul, Liming Zhang, Linda S Jozefiak, Lindsey Brown, PhD, Lisa J Joseph, Lisa L Flores, Lisa T Michel, Logan T Williams, LTJG Aaron B Otis, Luis Mburgos Medero, Marcellinus D Dordunoo, Margaret N Persich, Maria A Reed, Maria Cruz Fisher, Marlon K Turner, Martin R Vowell, Mary E Storch, Matthew H Hunt, Matthew T Sanchez, Meisha R Sampson, Meisha Waters, Melissa M Steiger, Miah I Schneider, Michael A Charles, Michael E Maselli, Michael G Truchan, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele Perry Williams, Michelle L Jones, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Muna Algharibeh, Natalie A Mickelsen, DVM, Nicholas A Violand, Nicholas E Boyd, Nicholas L Paulin, Nicholas P Diorio, Nicholas Z Lu, Nicole A Lloyd, Nicole E Knowlton, Omotunde O Osunsanmi, Owens, Paranthaman Senthamaraikannan, Patsy J Domingo, Peng Zhou, Phenicia T Petty, Phenicia T Wedgeworth, Pifer, Prabhu P Raju, Rabia Ballica, PhD, Rafeeq A Habeeb, Rasha Bamieh, Raymond R Roy, PhD, Rebecca E Dombrowski, Reginald Walker, Renee L Rice, PhD, Richard W Thornton, Robert Barbosa, Robert J Ham, Robert J Martin, Robert M Barbosa, Robert P Whisenant, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Rose Ashley, Ross J Grigsby, Ryan J Benedict, Salwa K Poole, Samantha J Bradley, Sandra A Boyd, Sanket N Patel, Santiago Gallardo Johnson, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Scott R Nichols, PhD, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Steven D Kehoe, Susan M Jackson, Susan T Hadman, That Q Dang, Thomas A Peter, Thomas J Arista, Timothy J Schmidt, Tina M Pawlowski, Tina S Roecklein, Todd M Stankewicz, Tracey L Siebesma, Twana R Chandler, Vaishali J Patel, Victoria A Murray, Vioela J Caze, Virginia Carroll, PhD, Warren J Lopicka, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, Wendy M Stark, William A Warnick, William C Gilbert, William D Tingley, William G Craig, William G Nelson, William R Brubaker, Xiaohui Shen, Yanming An, PhD, Yuan Chia Kuo, Zachary A Bogorad, Zhong Li, PhD

Emilie E Kahn's Documents

Publish Date Document Type Title
June, 2018 FDA 483 Baxter Oncology GmbH - Form 483, 2018-06-14
June, 2016 EIR Corteva Agriscience LLC - EIR, 2016-06-08
April, 2017 FDA 483 Response Coram Healthcare Corp. of Indiana - Form 483R, 2017-05-31
March, 2017 FDA 483 Response ENDO USA, Inc. - Form 483R, 2017-03-31
September, 2018 FDA 483 IntegraDose Compounding Services LLC - Form 483, 2018-09-19
October, 2017 EIR Elba, Inc. - EIR, 2017-10-05
February, 2018 FDA 483 Lannett Company, Inc. - Form 483, 2018-02-02
August, 2019 FDA 483 Ernest Jackson & Co Ltd - Form 483, 2019-08-08
June, 2019 FDA 483 Sage Products LLC - Form 483, 2019-07-11
March, 2016 EIR Pharmakon Pharmaceuticals, Inc. - EIR, 2016-03-16
November, 2018 EIR Nukemed, Inc dba SpectronRx - EIR, 2018-11-14
December, 2019 FDA 483 Apotheca Company - Form 483, 2019-12-06
May, 2017 EIR Catalent Indiana, LLC - EIR, 2017-05-19
May, 2017 FDA 483 Catalent Indiana, LLC - Form 483, 2017-05-19
April, 2018 FDA 483 Infuscience Inc - Form 483, 2018-04-25
October, 2017 FDA 483 Response Elba, Inc. - Form 483R, 2017-11-16
December, 2017 FDA 483 AMERICAN PHARMACEUTICAL INGREDIENTS LLC d.b.a American Pharmaceutical Distributors - Form 483, 2017-12-14
June, 2016 FDA 483 Ecolab Inc. - Form 483, 2016-06-24
December, 2016 FDA 483 Huron Pharmaceuticals, Inc. - Form 483, 2016-12-22
April, 2017 EIR Coram Healthcare Corp. of Indiana - EIR, 2017-04-26
April, 2017 FDA 483 Coram Healthcare Corp. of Indiana - Form 483, 2017-04-26
September, 2019 EIR Dynalabs, LLC - EIR, 2019-09-26
March, 2016 FDA 483 Pharmakon Pharmaceuticals, Inc. - Form 483, 2016-03-16
January, 2017 FDA 483 Linde Gas & Equipment Inc. - Form 483, 2017-01-12
July, 2018 FDA 483 Omega Plastics Inc. - Form 483, 2018-07-20
March, 2017 EIR ENDO USA, Inc. - EIR, 2017-03-13
February, 2019 FDA 483 Response Barbara Ann Karmanos Cancer Hospital - Form 483R, 2019-02-18
December, 2016 FDA 483 Response Huron Pharmaceuticals, Inc. - Form 483R, 2017-05-16
March, 2017 FDA 483 ENDO USA, Inc. - Form 483, 2017-03-13
February, 2018 FDA 483 Response Lannett Company, Inc. - Form 483R, 2018-02-16
October, 2017 FDA 483 Elba, Inc. - Form 483, 2017-10-05
February, 2019 FDA 483 Barbara Ann Karmanos Cancer Hospital - Form 483, 2019-02-04
January, 2017 EIR Linde Gas & Equipment Inc. - EIR, 2017-01-12
January, 2018 FDA 483 Techni Med, Inc. dba The Compounder - Form 483, 2018-01-26
November, 2016 EIR The Harvard Drug Group - EIR, 2016-11-01
November, 2016 FDA 483 King Pharmaceuticals LLC - Form 483, 2016-11-21
September, 2019 FDA 483 Dynalabs, LLC - Form 483, 2019-09-26
January, 2019 EIR Morton Salt, Inc. - EIR, 2019-01-10
December, 2019 FDA 483 Future Pak LLC - Form 483, 2019-12-12
February, 2018 EIR Lannett Company, Inc. - EIR, 2018-02-02
June, 2017 FDA 483 Diversified Pharmacy Inc dba University Compounding Pharmacy - Form 483, 2017-06-19
February, 2019 EIR Barbara Ann Karmanos Cancer Hospital - EIR, 2019-02-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more